THE ANTIOSTEOPOROTIC POTENTIAL OF HESPERIDIN AND ADVANCED DELIVERY SYSTEMS
DOI:
https://doi.org/10.22159/ijap.2025v17i3.53661Keywords:
HP, OP, Advanced drug delivery systemsAbstract
This study explores Hesperidin (HP) and its bone-protective effect against Osteoporosis (OP), summarizing its healing mechanisms supported by in vitro and in vivo evidence and insights into its ethnobotanical significance and advanced drug delivery systems. To gather information on the antiosteoporotic potential of HP, we thoroughly searched many scientific databases, including Science Direct, Google Scholar, PubMed, and Scopus, for articles published between 1990 and 2025. Data were collected using the keywords HP, traditional uses, phytochemistry, anti-OP, and drug delivery systems. Only studies published in English are considered for this review. It has gained attention for potential health benefits, especially the osteoprotective effect. In vitro studies found that HP reverses dexamethasone-induced inhibition of osteogenic differentiation by suppressing the p53 (Protein 53) pathway. In rat models of Postmenopausal (PM), senile, and disuse OP, HP showed bone-protective benefits. Clinical trials revealed a 15% increase in serum calcium and a 25% increase in osteocalcin levels, indicating enhanced bone formation. Comparative analysis showed that HP's efficacy in increasing bone mineral density is similar to that of bisphosphonates. The findings demonstrate that HP is an excellent therapeutic candidate that protects the skeleton through various mechanisms. Future research should focus on developing HP-based nutraceuticals or pharmaceuticals, integrating traditional knowledge with modern pharmacological approaches to enhance bone health. Despite its potential, the efficacy of HP formulations in treating OP has not yet been investigated.
References
Ahmad Hairi H, Jayusman PA, Shuid AN. Revisiting resveratrol as an osteoprotective agent: molecular evidence from in vivo and in vitro studies. Biomedicines. 2023 May 16;11(5):1453. doi: 10.3390/biomedicines11051453, PMID 37239124.
Shah A, Gourishetti K, Nayak Y. Osteogenic activity of resveratrol in human fetal osteoblast cells. Phcog Mag. 2019;15(64):250-5. doi: 10.4103/pm.pm_619_18.
Miguez PA, Tuin SA, Robinson AG, Belcher J, Jongwattanapisan P, Perley K. Hesperidin promotes osteogenesis and modulates collagen matrix organization and mineralization in vitro and in vivo. Int J Mol Sci. 2021 Mar 22;22(6):3223. doi: 10.3390/ijms22063223, PMID 33810030.
Yang J, Cong N, Shi D, Chen S, Zhang Z, Zhao P. Siwu decoction exerts a phytoestrogenic osteoprotective effect on postmenopausal osteoporosis via the estrogen receptor/phosphatidylinositol 3-kinase/serine/threonine protein kinase pathway. J Ethnopharmacol. 2024 May 18;332:118366. doi: 10.1016/j.jep.2024.118366, PMID 38763371.
Khadilkar AV, Mandlik RM. Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health. 2015;7:841-50. doi: 10.2147/IJWH.S54623, PMID 26527900.
TU KN, Lie JD, Wan CK, Cameron M, Austel AG, Nguyen JK. Osteoporosis: a review of treatment options. Pharm Ther. 2018 Feb;43(2):92-104.
Wang C, Zeng R, LI Y, HE R. Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways. Chin Med. 2024 May 14;19(1):69. doi: 10.1186/s13020-024-00938-6, PMID 38745234.
Sahu TK, Shanmugam J, Sundaram G, Cannane S. Detection of bone marrow edema in vertebral compression fractures using third generation dual-energy computed tomography and virtual non-calcium techniques. Asian J Pharm Clin Res. 2024;17(9):19-21.
Florencio Silva R, Sasso GR, Sasso Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure function and factors that influence bone cells. Bio Med Res Int. 2015;2015:421746. doi: 10.1155/2015/421746, PMID 26247020.
Xiao D, Huang S, Tang Z, Liu M, DI D, MA Y. Mijiao formula regulates NAT10-mediated Runx2 mRNA ac4C modification to promote bone marrow mesenchymal stem cell osteogenic differentiation and improve osteoporosis in ovariectomized rats. J Ethnopharmacol. 2024 Aug 10;330:118191. doi: 10.1016/j.jep.2024.118191, PMID 38621468.
Huang CY, Cheng CJ, Chiou WF, Chang WC, Kang YN, Lee MH. Efficacy and safety of duhuo jisheng decoction add on bisphosphonate medications in patients with osteoporosis: a meta-analysis of randomized controlled trials. J Ethno pharmacol. 2022 Jan 30;283:114732. doi: 10.1016/j.jep.2021.114732, PMID 34637967.
Ahmed H, Aboul Enein A, Abou Elella F, Salem S, Aly H, Nassrallah A. Nano-formulations of hesperidin and essential oil extracted from sweet orange peel: chemical properties and biological activities. Egypt J Chem. 2021 Aug 4;64(9):5373-85. doi: 10.21608/ejchem.2021.84783.4139.
Agrawal PK, Agrawal C, Blunden G. Pharmacological significance of hesperidin and hesperetin two citrus flavonoids as promising antiviral compounds for prophylaxis against and combating COVID-19. Nat Prod Commun. 2021 Oct 1;16(10). doi: 10.1177/1934578X211042540.
Beederman M, Lamplot JD, Nan G, Wang J, Liu X, Yin L. BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng. 2013 Aug;6(8A):32-52. doi: 10.4236/jbise.2013.68A1004, PMID 26819651.
Baron R, Gori F. Targeting WNT signaling in the treatment of osteoporosis. Curr Opin Pharmacol. 2018 Jun 1;40:134-41. doi: 10.1016/j.coph.2018.04.011, PMID 29753194.
Almukainzi M, El Masry TA, El Zahaby EI, El Nagar MM. Chitosan/hesperidin nanoparticles for sufficient compatible antioxidant and antitumor drug delivery systems. Pharmaceuticals (Basel). 2024 Jul 29;17(8):999. doi: 10.3390/ph17080999, PMID 39204104.
Lee H, Kim MH, Choi Y, Yang WM. Ameliorative effects of Osteo-F, a newly developed herbal formula on osteoporosis via activation of bone formation. J Ethnopharmacol. 2021 Mar 25;268:113590. doi: 10.1016/j.jep.2020.113590, PMID 33212177.
Viju KK, Shah MR. Awareness of delayed healing in post-operative fracture conditions in osteoporotic patients. Asian J Pharm Clin Res. 2024;17(6):146-8. doi: 10.22159/ajpcr.2024.v17i6.50642.
Sozen T, Ozısık L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017 Mar;4(1):46-56. doi: 10.5152/eurjrheum.2016.048, PMID 28293453.
Cheng CH, Chen LR, Chen KH. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci. 2022 Jan 25;23(3):1376. doi: 10.3390/ijms23031376, PMID 35163300.
Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014 Jul;142:155-70. doi: 10.1016/j.jsbmb.2013.09.008, PMID 24176761.
LU Y, Zhang M, Zhang J, Jiang M, Bai G. Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2. J Ethnopharmacol. 2023 Jul 15;311:116426. doi: 10.1016/j.jep.2023.116426, PMID 36997132.
Dunstan C, Blair J, Zhou HM, Seibel MJ. Bone mineral connective tissue metabolism. Compr Med Chem. 2006 Nov 1;6:495-520.
Hart NH, Newton RU, Tan J, Rantalainen T, Chivers P, Siafarikas A. Biological basis of bone strength: anatomy physiology and measurement. J Musculoskelet Neuronal Interact. 2020;20(3):347-71. PMID 32877972.
Blair HC, Larrouture QC, LI Y, Lin H, Beer Stoltz D, Liu L. Osteoblast differentiation and bone matrix formation in vivo and in vitro. Tissue Eng Part B Rev. 2017 Jun 1;23(3):268-80. doi: 10.1089/ten.TEB.2016.0454, PMID 27846781.
Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S131-9. doi: 10.2215/CJN.04151206, PMID 18988698.
Nair AK, Gautieri A, Chang SW, Buehler MJ. Molecular mechanics of mineralized collagen fibrils in bone. Nat Commun. 2013;4:1724. doi: 10.1038/ncomms2720, PMID 23591891.
Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast osteoclast communication and bone homeostasis. Cells. 2020 Sep 10;9(9):2073. doi: 10.3390/cells9092073, PMID 32927921.
Foster BM, Shi L, Harris KS, Patel C, Surratt VE, Langsten KL. Bone marrow derived stem cell factor regulates prostate cancer induced shifts in pre-metastatic niche composition. Front Oncol. 2022;12:855188. doi: 10.3389/fonc.2022.855188, PMID 35515124.
Siddiqui JA, Partridge NC. Physiological bone remodeling: systemic regulation and growth factor involvement. Physiology (Bethesda). 2016 May;31(3):233-45. doi: 10.1152/physiol.00061.2014, PMID 27053737.
Kanczler J, Wells J, Gibbs D, Marshall K, Tang DK, Oreffo R. Bone tissue engineering and bone regeneration; 2020. p. 917-35.
Anam AK, Insogna K. Update on osteoporosis screening and management. Med Clin North Am. 2021 Nov;105(6):1117-34. doi: 10.1016/j.mcna.2021.05.016, PMID 34688418.
Weitzmann MN. Bone and the immune system. Toxicol Pathol. 2017 Oct;45(7):911-24. doi: 10.1177/0192623317735316, PMID 29046115.
Murshed M. Mechanism of bone mineralization. Cold Spring Harb Perspect Med. 2018 Dec;8(12):a031229. doi: 10.1101/cshperspect.a031229, PMID 29610149.
Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006 Dec 1;99(5):1233-9. doi: 10.1002/jcb.20958, PMID 16795049.
Kim JH, Liu X, Wang J, Chen X, Zhang H, Kim SH. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis. 2013 Feb;5(1):13-31. doi: 10.1177/1759720X12466608, PMID 23514963.
Mazemondet O, Hubner R, Frahm J, Koczan D, Bader BM, Weiss DG. Quantitative and kinetic profile of Wnt/β-catenin signaling components during human neural progenitor cell differentiation. Cell Mol Biol Lett. 2011 Dec;16(4):515-38. doi: 10.2478/s11658-011-0021-0, PMID 21805133.
Park JH, Lee NK, Lee SY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol Cells. 2017 Oct 31;40(10):706-13. doi: 10.14348/molcells.2017.0225, PMID 29047262.
Collison J. Osteoporosis: teriparatide preferable for fracture prevention. Nat Rev Rheumatol. 2018 Jan;14(1):4. doi: 10.1038/nrrheum.2017.194, PMID 29167546.
Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992 Nov 1;2(6):285-9. doi: 10.1007/BF01623184, PMID 1421796.
Chaugule SR, Indap MM, Chiplunkar SV. Marine natural products: new avenue in treatment of osteoporosis. Front Mar Sci. 2017 Nov 29;4. doi: 10.3389/fmars.2017.00384.
Leder BZ, Mitlak B, HU MY, Hattersley G, Bockman RS. Effect of abaloparatide vs alendronate on fracture risk reduction in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2020;105(3):938-43. doi: 10.1210/clinem/dgz162, PMID 31674644.
Merlotti D, Falchetti A, Chiodini I, Gennari L. Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis. Expert Opin Pharmacother. 2019 May;20(7):805-11. doi: 10.1080/14656566.2019.1583208, PMID 30856013.
Sindel D. Osteoporosis: spotlight on current approaches to pharmacological treatment. Turk J Phys Med Rehabil. 2023 May 15;69(2):140-52. doi: 10.5606/tftrd.2023.13054, PMID 37671373.
Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G. Efficacy of tissue selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at risk postmenopausal women. Fertil Steril. 2009 Sep 1;92(3):1045-52. doi: 10.1016/j.fertnstert.2009.02.093, PMID 19635616.
Zhou Z, Wang N, Ding C, Zhou X, Zhou J. Postmenopausal osteoporosis treated with acupoint injection of salmon calcitonin:a randomized controlled trial. Zhongguo Zhen Jiu. 2016 Jul 12;36(7):705-8. doi: 10.13703/j.0255-2930.2016.07.008, PMID 29231409.
Kobayakawa T, Miyazaki A, Saito M, Suzuki T, Takahashi J, Nakamura Y. Denosumab versus romosozumab for postmenopausal osteoporosis treatment. Sci Rep. 2021 Jun 3;11(1):11801. doi: 10.1038/s41598-021-91248-6, PMID 34083636.
Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause. 2003 Jul;10(4):337-44. doi: 10.1097/01.GME.0000058772.59606.2A, PMID 12851517.
Vestergaard P, Hermann AP, Gram J, Jensen LB, Kolthoff N, Abrahamsen B. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas. 1997 Dec 15;28(2):137-45. doi: 10.1016/s0378-5122(97)00076-5, PMID 9522321.
Vincent A, Riggs BL, Atkinson EJ, Oberg AL, Khosla S. Effect of estrogen replacement therapy on parathyroid hormone secretion in elderly postmenopausal women. Menopause N Y N. 2003 Mar;10(2):165-71.
Wein MN, Kronenberg HM. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med. 2018 Aug 1;8(8):a031237. doi: 10.1101/cshperspect.a031237, PMID 29358318.
Singh S, Dutta S, Khasbage S, Kumar T, Sachin J, Sharma J. A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis. Osteoporos Int. 2022 Jan;33(1):1-12. doi: 10.1007/s00198-021-06095-y, PMID 34432115.
Kendler DL, Marin F, Zerbini CA, Russo LA, Greenspan SL, Zikan V. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre double blind double dummy randomised controlled trial. Lancet. 2018 Jan 20;391(10117):230-40. doi: 10.1016/S0140-6736(17)32137-2, PMID 29129436.
Huang H, Cheng Z, Shi H, Xin W, Wang TT, YU LL. Isolation and characterization of two flavonoids engeletin and astilbin from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties. J Agric Food Chem. 2011 May 11;59(9):4562-9. doi: 10.1021/jf2002969, PMID 21476602.
Jin H, Wang Q, Chen K, XU K, Pan H, Chu F. Astilbin prevents bone loss in ovariectomized mice through the inhibition of rankl induced osteoclastogenesis. J Cell Mol Med. 2019 Dec;23(12):8355-68. doi: 10.1111/jcmm.14713, PMID 31603626.
LI SF, Tang JJ, Chen J, Zhang P, Wang T, Chen TY. Regulation of bone formation by baicalein via the mTORC1 pathway. Drug Des Dev Ther. 2015;9:5169-83. doi: 10.2147/DDDT.S81578, PMID 26392752.
Liao H, YE J, Gao L, Liu Y. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: a comprehensive review. Biomed Pharmacother. 2021 Jan;133:110917. doi: 10.1016/j.biopha.2020.110917, PMID 33217688.
Wang D, LI F, Jiang Z. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med. 2001 Nov;67(8):748-9. doi: 10.1055/s-2001-18343, PMID 11731919.
Adil M, Mansoori MN, Singh D, Kandhare AD, Sharma M. Pioglitazone induced bone loss in diabetic rats and its amelioration by berberine: a portrait of molecular crosstalk. Biomed Pharmacother. 2017 Oct;94:1010-9. doi: 10.1016/j.biopha.2017.08.001, PMID 28810524.
Yogesh HS, Chandrashekhar VM, Katti HR, Ganapaty S, Raghavendra HL, Gowda GK. Anti-osteoporotic activity of aqueous methanol extract of Berberis aristata in ovariectomized rats. J Ethnopharmacol. 2011 Mar 24;134(2):334-8. doi: 10.1016/j.jep.2010.12.013, PMID 21182919.
Park KR, Park JE, Kim B, Kwon IK, Hong JT, Yun HM. Calycosin-7-O-β-Glucoside isolated from astragalus membranaceus promotes osteogenesis and mineralization in human mesenchymal stem cells. Int J Mol Sci. 2021 Oct 21;22(21):11362. doi: 10.3390/ijms222111362, PMID 34768792.
Quan GH, Wang H, Cao J, Zhang Y, WU D, Peng Q. Calycosin suppresses rankl-mediated osteoclastogenesis through inhibition of MAPKs and NF-κB. Int J Mol Sci. 2015 Dec 10;16(12):29496-507. doi: 10.3390/ijms161226179, PMID 26690415.
Choi EM, Hwang JK. Effects of (+)-catechin on the function of osteoblastic cells. Biol Pharm Bull. 2003 Apr;26(4):523-6. doi: 10.1248/bpb.26.523, PMID 12673036.
Ivanov SA, Nomura K, Malfanov IL, Sklyar IV, Ptitsyn LR. Isolation of a novel catechin from bergenia rhizomes that has pronounced lipase inhibiting and antioxidative properties. Fitoterapia. 2011 Mar;82(2):212-8. doi: 10.1016/j.fitote.2010.09.013, PMID 20923698.
Hosny M, Zheng MS, Zhang H, Chang HW, Woo MH, Son JK. (–)-Catechin glycosides from Ulmus davidiana. Arch Pharm Res. 2014 Jun;37(6):698-705. doi: 10.1007/s12272-013-0264-6, PMID 24155021.
YU AX, XU ML, Yao P, Kwan KK, Liu YX, Duan R. Corylin a flavonoid derived from psoralea fructus induces osteoblastic differentiation via estrogen and Wnt/β-catenin signaling pathways. FASEB J. 2020 Mar;34(3):4311-28. doi: 10.1096/fj.201902319RRR, PMID 31965654.
Chen L, Xin X, Lan R, Yuan Q, Wang X, LI Y. Isolation of cyanidin 3-glucoside from blue honeysuckle fruits by high speed counter current chromatography. Food Chem. 2014;152:386-90. doi: 10.1016/j.foodchem.2013.11.080, PMID 24444952.
HU B, Chen L, Chen Y, Zhang Z, Wang X, Zhou B. Cyanidin-3-glucoside regulates osteoblast differentiation via the ERK1/2 signaling pathway. ACS Omega. 2021 Feb 23;6(7):4759-66. doi: 10.1021/acsomega.0c05603, PMID 33644583.
Fan C, LI N, Cao X, Wen L. Ionic liquid modified countercurrent chromatographic isolation of high purity delphinidin-3-rutinoside from eggplant peel. J Food Sci. 2020 Apr;85(4):1132-9. doi: 10.1111/1750-3841.15089, PMID 32144797.
Imangali N, Phan QT, Mahady G, Winkler C. The dietary anthocyanin delphinidin prevents bone resorption by inhibiting rankl induced differentiation of osteoclasts in a medaka (Oryzias latipes) model of osteoporosis. J Fish Biol. 2021 Apr;98(4):1018-30. doi: 10.1111/jfb.14317, PMID 32155282.
Lee J, Noh AL, Zheng T, Kang JH, Yim M. Eriodicyol inhibits osteoclast differentiation and ovariectomy induced bone loss in vivo. Exp Cell Res. 2015 Dec 10;339(2):380-8. doi: 10.1016/j.yexcr.2015.10.001, PMID 26450448.
Vigbedor BY, Osei Akoto C, Neglo D. Isolation and identification of flavanone derivative eriodictyol from the methanol extract of Afzelia africana bark and its antimicrobial and antioxidant activities. Evid Based Complement Alternat Med. 2023;2023:9345047. doi: 10.1155/2023/9345047, PMID 37200890.
Kwon JE, Lim J, Kim I, Kim D, Kang SC. Isolation and identification of new bacterial stains producing equol from Pueraria lobata extract fermentation. Plos One. 2018;13(2):e0192490. doi: 10.1371/journal.pone.0192490, PMID 29447179.
Wang J, XU J, Wang B, Shu FR, Chen K, MI MT. Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor. Genet Mol Res. 2014 Jul 4;13(3):5055-63. doi: 10.4238/2014.July.4.21, PMID 25061730.
Huh JE, Lee WI, Kang JW, Nam D, Choi DY, Park DS. Formononetin attenuates osteoclastogenesis via suppressing the rankl induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway. J Nat Prod. 2014 Nov 26;77(11):2423-31. doi: 10.1021/np500417d, PMID 25397676.
Jiang B, Kronenberg F, Balick MJ, Kennelly EJ. Analysis of formononetin from black cohosh (Actaea racemosa). Phytomedicine. 2006 Jul;13(7):477-86. doi: 10.1016/j.phymed.2005.06.007, PMID 16785040.
Ming LG, Chen KM, Xian CJ. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol. 2013 Mar;228(3):513-21. doi: 10.1002/jcp.24158, PMID 22777826.
Wang ST, Chang HS, Hsu C, SU NW. Osteoprotective effect of genistein 7-O-phosphate a derivative of genistein with high bioavailability in ovariectomized rats. J Funct Foods. 2019 Jul 1;58:171-9.
Winzer M, Rauner M, Pietschmann P. Glycitein decreases the generation of murine osteoclasts and increases apoptosis. Wien Med Wochenschr. 2010;160(17-18):446-51. doi: 10.1007/s10354-010-0811-4, PMID 20714813.
QU LP, Fan GR, Peng JY, MI HM. Isolation of six isoflavones from semen sojae praeparatum by preparative HPLC. Fitoterapia. 2007 Apr;78(3):200-4. doi: 10.1016/j.fitote.2006.11.002, PMID 17343991.
HU HY, Zhang ZZ, Jiang XY, Duan TH, Feng W, Wang XG. Hesperidin anti-osteoporosis by regulating estrogen signaling pathways. Molecules. 2023 Oct 9;28(19):6987. doi: 10.3390/molecules28196987, PMID 37836830.
Kilor VA. Design and development of novel microemulsion based topical formulation of hesperidin. Int J Pharm Pharm Sci. 2015;7(12):142-8.
Xue L, Jiang Y, Han T, Zhang N, Qin L, Xin H. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim. J Ethnopharmacol. 2016 Nov 4;192:370-81. doi: 10.1016/j.jep.2016.07.037, PMID 27422162.
Zhou F, Mei J, Yuan K, Han X, Qiao H, Tang T. Isorhamnetin attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes through modulating reactive oxygen species homeostasis. J Cell Mol Med. 2019 Jun;23(6):4395-407. doi: 10.1111/jcmm.14333, PMID 30983153.
Suleiman RK, Umoren SA, Iali W, El Ali B. Isolation of new constituents from whole plant of salsola imbricataforssk of Saudi Origin. ACS Omega. 2022 Jun 14;7(23):20332-8. doi: 10.1021/acsomega.2c02332, PMID 35721930.
Yang L, Chen Q, Wang F, Zhang G. Antiosteoporotic compounds from seeds of Cuscuta chinensis. J Ethnopharmacol. 2011 May 17;135(2):553-60. doi: 10.1016/j.jep.2011.03.056, PMID 21463675.
Hakem A, Desmarets L, Sahli R, Malek RB, Camuzet C, François N. Luteolin isolated from Juncus acutus L. a potential remedy for human coronavirus 229E. Molecules. 2023 May 23;28(11):4263. doi: 10.3390/molecules28114263, PMID 37298740.
Quan H, Dai X, Liu M, WU C, Wang D. Luteolin supports osteogenic differentiation of human periodontal ligament cells. BMC Oral Health. 2019 Oct 26;19(1):229. doi: 10.1186/s12903-019-0926-y, PMID 31655580.
Gui H, Dai J, Tian J, Jiang Q, Zhang Y, Ren G. The isolation of anthocyanin monomers from blueberry pomace and their radical scavenging mechanisms in DFT study. Food Chem. 2023 Aug 30;418:135872. doi: 10.1016/j.foodchem.2023.135872, PMID 37001355.
Mao W, Huang G, Chen H, XU L, Qin S, LI A. Research progress of the role of anthocyanins on bone regeneration. Front Pharmacol. 2021;12:773660. doi: 10.3389/fphar.2021.773660, PMID 34776985.
Fan S, Gao X, Chen P, LI X. Myricetin ameliorates glucocorticoid induced osteoporosis through the ERK signaling pathway. Life Sci. 2018 Aug 15;207:205-11. doi: 10.1016/j.lfs.2018.06.006, PMID 29883721.
Jeyaraj EJ, Lim YY, Choo WS. Extraction methods of butterfly pea (Clitoria ternatea) flower and biological activities of its phytochemicals. J Food Sci Technol. 2021 Jun;58(6):2054-67. doi: 10.1007/s13197-020-04745-3, PMID 33967304.
Mohd Ramli ES, Suhaimi F, Ahmad F, Shuid AN, Mohamad N, Ima Nirwana S. piper sarmentosum: a new hope for the treatment of osteoporosis. Curr Drug Targets. 2013 Dec;14(14):1675-82. doi: 10.2174/13894501113146660228, PMID 24107234.
Sharma A, Bhardwaj P, Arya SK. Naringin: a potential natural product in the field of biomedical applications. Carbohydrate Polymer Technologies and Applications. 2021 Dec 25;2:100068. doi: 10.1016/j.carpta.2021.100068.
LI S, YU H, HO CT. Nobiletin: efficient and large quantity isolation from orange peel extract. Biomed Chromatogr. 2006;20(1):133-8. doi: 10.1002/bmc.540, PMID 15999338.
Tominari T, Hirata M, Matsumoto C, Inada M, Miyaura C. Polymethoxy flavonoids nobiletin and tangeretin prevent lipopolysaccharide induced inflammatory bone loss in an experimental model for periodontitis. J Pharmacol Sci. 2012;119(4):390-4. doi: 10.1254/jphs.11188sc, PMID 22850615.
Ren Z, Raut NA, Lawal TO, Patel SR, Lee SM, Mahady GB. Peonidin-3-O-glucoside and cyanidin increase osteoblast differentiation and reduce RANKL-induced bone resorption in transgenic medaka. Phytother Res. 2021 Nov;35(11):6255-69. doi: 10.1002/ptr.7271, PMID 34704297.
Ichiyanagi T, Kashiwada Y, Nashimoto M. Large scale isolation of three O-methyl anthocyanins from bilberry (Vaccinium myrtillus L.) extract. Chem Pharm Bull (Tokyo). 2020 Nov 1;68(11):1113-6. doi: 10.1248/cpb.c20-00593, PMID 32879234.
Nagaoka M, Maeda T, Moriwaki S, Nomura A, Kato Y, Niida S. Petunidin a B-ring 5′-O-methylated derivative of delphinidin stimulates osteoblastogenesis and reduces sRANKL-induced bone loss. Int J Mol Sci. 2019 Jun 7;20(11):2795. doi: 10.3390/ijms20112795, PMID 31181661.
Huang YL, Shen CC, Shen YC, Chiou WF, Chen CC. Anti-inflammatory and antiosteoporosis flavonoids from the rhizomes of Helminthostachys zeylanica. J Nat Prod. 2017 Feb 24;80(2):246-53. doi: 10.1021/acs.jnatprod.5b01164, PMID 28169537.
Irnidayanti Y, Maharani DG, Rizky MH, Noer MI, Rizkawati V. Resveratrol-tempeh reduce micronucleus frequencies bone marrow cells and stimulate osteocyte proliferation in aluminum chloride induced mice. Braz J Biol. 2023 Feb 3;82:e266690. doi: 10.1590/1519-6984.266690, PMID 36753089.
Wang DG, Liu WY, Chen GT. A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum. J Pharm Anal. 2013 Aug 1;3(4):241-7. doi: 10.1016/j.jpha.2012.12.001, PMID 29403824.
Abdel Naim AB, Alghamdi AA, Algandaby MM, Al Abbasi FA, Al Abd AM, Eid BG. Rutin isolated from Chrozophora tinctoria enhances bone cell proliferation and ossification markers. Oxid Med Cell Longev. 2018 Feb 13;2018:5106469. doi: 10.1155/2018/5106469, PMID 29636845.
Seal T, Chaudhuri K. Effect of solvent extraction system on the antioxidant activities of some selected wild edible plants used by the ethnic people of Arunachal Pradesh. Int J Curr Pharm Rev Res. 2016;7(3):180-5.
Mak NK, Wong Leung YL, Chan SC, Wen J, Leung KN, Fung MC. Isolation of anti-leukemia compounds from Citrus reticulata. Life Sci. 1996;58(15):1269-76. doi: 10.1016/0024-3205(96)00088-4, PMID 8614280.
Liu X, Liu W, Ding C, Zhao Y, Chen X, Ling D. Taxifolin extracted from waste larix olgensis roots attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR and TGF-β1/Smads signaling pathways. Drug Des Dev Ther. 2021;15:871-87. doi: 10.2147/DDDT.S281369, PMID 33664566.
Bansal K, Bhati H, Vanshita BM, Bajpai M. New insights into therapeutic applications and nanoformulation approaches of hesperidin: an updated review. Pharmacological Research Modern Chinese Medicine. 2024 Mar;10:100363. doi: 10.1016/j.prmcm.2024.100363.
Hosawi S. Current update on role of hesperidin in inflammatory lung diseases: chemistry pharmacology and drug delivery approaches. Life (Basel). 2023 Apr 3;13(4):937. doi: 10.3390/life13040937, PMID 37109466.
Choi SS, Lee SH, Lee KA. A comparative study of hesperetin hesperidin and hesperidin glucoside: antioxidant anti-inflammatory and antibacterial activities in vitro. Antioxidants (Basel). 2022 Aug 20;11(8):1618. doi: 10.3390/antiox11081618, PMID 36009336.
LI C, Schluesener H. Health promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2017 Feb 11;57(3):613-31. doi: 10.1080/10408398.2014.906382, PMID 25675136.
Stanisic D, Liu LH, Dos Santos RV, Costa AF, Duran N, Tasic L. New sustainable process for hesperidin isolation and anti-ageing effects of hesperidin nanocrystals. Molecules. 2020 Oct 3;25(19):4534. doi: 10.3390/molecules25194534, PMID 33022944.
Ortiz A DE C, Fideles SO, Reis CH, Bellini MZ, DE Pereira ES, Pilon JP. Therapeutic effects of citrus flavonoids neohesperidin hesperidin and its aglycone hesperetin on bone health. Biomolecules. 2022 Apr 23;12(5):626. doi: 10.3390/biom12050626, PMID 35625554.
Grohmann K, Manthey JA, Cameron RG. Acid catalyzed hydrolysis of hesperidin at elevated temperatures. Carbohydr Res. 2000 Sep 8;328(2):141-6. doi: 10.1016/s0008-6215(00)00081-1, PMID 11028782.
Rosiak N, Wdowiak K, Tykarska E, Cielecka Piontek J. Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases. Int J Mol Sci. 2022 Dec 2;23(23):15198. doi: 10.3390/ijms232315198, PMID 36499518.
Majumdar S, Srirangam R. Solubility stability physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid. Pharm Res. 2009 May;26(5):1217-25. doi: 10.1007/s11095-008-9729-6, PMID 18810327.
Altunayar Unsalan C, Unsalan O, Mavromoustakos T. Molecular interactions of hesperidin with DMPC/cholesterol bilayers. Chem Biol Interact. 2022 Oct 1;366:110131. doi: 10.1016/j.cbi.2022.110131, PMID 36037876.
Wdowiak K, Walkowiak J, Pietrzak R, Bazan Wozniak A, Cielecka Piontek J. Bioavailability of hesperidin and its aglycone hesperetin compounds found in citrus fruits as a parameter conditioning the pro-health potential (neuroprotective and antidiabetic activity) mini-review. Nutrients. 2022 Jun 26;14(13):2647. doi: 10.3390/nu14132647, PMID 35807828.
Pyrzynska K. Hesperidin: a review on extraction methods stability and biological activities. Nutrients. 2022 Jun;14(12):2387. doi: 10.3390/nu14122387, PMID 35745117.
Guazelli CF, Fattori V, Ferraz CR, Borghi SM, Casagrande R, Baracat MM. Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis. Chem Biol Interact. 2021 Jan 5;333:109315. doi: 10.1016/j.cbi.2020.109315, PMID 33171134.
Yang HL, Chen SC, Senthil Kumar KJ, YU KN, Lee Chao PD, Tsai SY. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin administered rat serum: an ex vivo approach. J Agric Food Chem. 2012 Jan 11;60(1):522-32. doi: 10.1021/jf2040675, PMID 22098419.
Golboyu BE, Erdogan MA, Cosar MA, Balıkoglu E, Erbas O. Diosmin and hesperidin have a protective effect in diabetic neuropathy via the FGF21 and galectin-3 pathway. Medicina (Kaunas). 2024 Oct;60(10):1580. doi: 10.3390/medicina60101580, PMID 39459367.
Hong W, Zhang W. Hesperidin promotes differentiation of alveolar osteoblasts via Wnt/β-catenin signaling pathway. J Recept Signal Transduct Res. 2020 Oct;40(5):442-8. doi: 10.1080/10799893.2020.1752718, PMID 32308087.
Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N. Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol. 2003 Nov;163(5):2021-31. doi: 10.1016/s0002-9440(10)63560-2, PMID 14578201.
Zhang M, Chen D, Zeng N, Liu Z, Chen X, Xiao H. Hesperidin ameliorates dexamethasone induced osteoporosis by inhibiting p53. Front Cell Dev Biol. 2022 Apr 11;10:820922. doi: 10.3389/fcell.2022.820922, PMID 35478958.
Chiba H, Uehara M, WU J, Wang X, Masuyama R, Suzuki K. Hesperidin a citrus flavonoid inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr. 2003 Jun;133(6):1892-7. doi: 10.1093/jn/133.6.1892, PMID 12771335.
Horcajada MN, Habauzit V, Trzeciakiewicz A, Morand C, Gil-Izquierdo A, Mardon J. Hesperidin inhibits ovariectomized induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. Journal of Applied Physiology. 2008;104(3):648-54. doi: 10.1152/japplphysiol.00441.2007.
Zhang Q, Song X, Chen X, Jiang R, Peng K, Tang X. Antiosteoporotic effect of hesperidin against ovariectomy induced osteoporosis in rats via reduction of oxidative stress and inflammation. J Biochem Mol Toxicol. 2021 Aug;35(8):e22832. doi: 10.1002/jbt.22832, PMID 34028927.
Martin BR, McCabe GP, McCabe L, Jackson GS, Horcajada MN, Offord Cavin E. Effect of hesperidin with and without a calcium (Calcilock) supplement on bone health in postmenopausal women. J Clin Endocrinol Metab. 2016 Mar;101(3):923-7. doi: 10.1210/jc.2015-3767, PMID 26751193.
Dayanandan AP, Cho WJ, Kang H, Bello AB, Kim BJ, Arai Y. Emerging nano scale delivery systems for the treatment of osteoporosis. Biomater Res. 2023 Jul 13;27(1):68. doi: 10.1186/s40824-023-00413-7, PMID 37443121.
Marimuthu A, Seenivasan R, Pachiyappan JK, Nizam I, Ganesh G. Synergy of science and tradition: a nanotechnology driven revolution in natural medicine. Int J App Pharm. 2024;16(6):10-20. doi: 10.22159/ijap.2024v16i6.50767.
Pradhan SP, Sahoo S, Behera A, Sahoo R, Sahu PK. Memory amelioration by hesperidin conjugated gold nanoparticles in diabetes induced cognitive impaired rats. J Drug Deliv Sci Technol. 2022 Mar 1;69:103145. doi: 10.1016/j.jddst.2022.103145.
Sarabia Vallejo A, Caja MD, Olives AI, Martin MA, Menendez JC. Cyclodextrin inclusion complexes for improved drug bioavailability and activity: synthetic and analytical aspects. Pharmaceutics. 2023 Sep 19;15(9):2345. doi: 10.3390/pharmaceutics15092345, PMID 37765313.
Hayat A, Shah I, Jabbar A, Nafady A, Balouch A, Shah MR. Enhanced wound healing activity in animal model via developing and designing of self nano emulsifying drug delivery system (SNEDDS) for the co-delivery of hesperidin and Rutin. J Clust Sci. 2024 Dec 1;35(8):2721-34. doi: 10.1007/s10876-024-02679-w.
Yaghoubi N, Gholamzad A, Naji T, Gholamzad M. In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: an insight into nano delivery system. BMC Biotechnol. 2024 Aug 2;24(1):52. doi: 10.1186/s12896-024-00882-1, PMID 39095760.
Dastanpour L, Kamali B, Ebrahimi G, Tadavani PK, Bashiri F, Pourjavadi A. Nanogram scale co-delivery of hesperidin and bicelin with high performance by redox and NIR-responsive nanotheranostic carrier. J Drug Deliv Sci Technol. 2024 Nov 1;101:106139. doi: 10.1016/j.jddst.2024.106139.
Almukainzi M, El Masry TA, El Zahaby EI, El Nagar MM. Chitosan/hesperidin nanoparticles for sufficient compatible antioxidant and antitumor drug delivery systems. Pharmaceuticals (Basel). 2024 Jul 29;17(8):999. doi: 10.3390/ph17080999, PMID 39204104.
LI J, Wang X, Guo H, Zhou H, Sha S, Yang Y. Immunostimulant citrus fruit derived extracellular vesicle nanodrugs for malignant glioma immunochemotherapy. Chem Eng J. 2024 Mar 15;484:149463. doi: 10.1016/j.cej.2024.149463.
Sun X, Yang H, Zhang H, Zhang W, Liu C, Wang X. Magnetic gelatin hesperidin microrobots promote proliferation and migration of dermal fibroblasts. Front Chem. 2024 Oct 10;12:1478338. doi: 10.3389/fchem.2024.1478338, PMID 39449692.
Kodous AS, Abdel Maksoud MA, El Tayeb MA, Al Sherif DA, Mohamed SS, Ghobashy MM. Hesperidin loaded PVA/alginate hydrogel: targeting NFκB/iNOS/COX-2/TNF-α inflammatory signaling pathway. Front Immunol. 2024 Apr 15;15:1347420. doi: 10.3389/fimmu.2024.1347420, PMID 38686374.
Jangde R, Elhassan GO, Khute S, Singh D, Singh M, Sahu RK. Hesperidin loaded lipid polymer hybrid nanoparticles for topical delivery of bioactive drugs. Pharmaceuticals (Basel). 2022 Feb 10;15(2):211. doi: 10.3390/ph15020211, PMID 35215324.
Sharaf M, Arif M, Khan S, Abdalla M, Shabana S, Chi Z. Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of helicobacter pylori in vitro. Bioorg Chem. 2021 Jul 1;112:104896. doi: 10.1016/j.bioorg.2021.104896, PMID 33901764.
LI Y, Kandhare AD, Mukherjee AA, Bodhankar SL. Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in sprague dawley rats. Regul Toxicol Pharmacol. 2019 Jul 1;105:77-85. doi: 10.1016/j.yrtph.2019.04.001, PMID 30991075.
Sharma P, Kumari S, Sharma J, Purohit R, Singh D. Hesperidin interacts with CREB-BDNF signaling pathway to suppress pentylenetetrazole induced convulsions in zebrafish. Front Pharmacol. 2020;11:607797. doi: 10.3389/fphar.2020.607797, PMID 33505312.
Published
How to Cite
Issue
Section
Copyright (c) 2025 VIJISHNA L. V., AKANKSHA D. DESSAI, USHA Y. NAYAK, RICHARD LOBO
This work is licensed under a Creative Commons Attribution 4.0 International License.
